MedTrace Logo

Effects of cogniVida™ on Learning and Memory and in Comparison to Placebo After Long-term Supplementation

NCT01647919 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 88

Last updated 2013-08-07

No results posted yet for this study

Summary

The purpose of the study is to examine the efficacy of cogniVida™ on learning and memory performance (executive function, associative, spatial and verbal memory) as well as on mood and attention parameters after four, eight and eleven weeks of supplementation and in comparison with placebo.

cogniVida™ is considered a dietary supplement, and therefore it is not an approved drug by the Food and Drug Administration (FDA). It is regulated like a food. The U.S. Food and Drug Administration does not strictly regulate herbs and dietary supplements. The investigators do not claim that this supplement is meant to treat any ailment.

Conditions

  • Healthy

Interventions

DIETARY_SUPPLEMENT

cogniVida™ 100 mg/day

4 capsules 25 mg (total 100 mg) cogniVida™ once a day

DIETARY_SUPPLEMENT

Placebo

4 capsules of placebo identical to cogniVida™ once a day

Sponsors & Collaborators

  • DSM Nutritional Products, Inc.

    lead INDUSTRY

Principal Investigators

  • David Kennedy, Prof · Director of the 'Brain, Performance and Nutrition Research Centre', Northumbria University, UK

  • Crystal Haskell, PhD · Associate Director of the 'Brain, Performance and Nutrition Research Centre', Northumbria University, UK

Study Design

Allocation
RANDOMIZED
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-05-31
Primary Completion
2013-05-31
Completion
2013-05-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01647919 on ClinicalTrials.gov